SMART PILL DISPENSER AT THE HOSPITAL BEDSIDE

Company specifications

The company, through R&D activities, aims to provide hospitals with innovative hybrid (digital/traditional) solutions that improve adherence to therapy and patient outcomes: the drug dispenser it has developed has in fact originated two patent applications (industrial invention + utility model). The benefits of this technology involve several areas: - patient health: correct intake (avoiding delays/doses not administered/errors/checking expiry date/patient allergies) and consequently maximum effectiveness of therapy, reduction of complications and mortality frees up paramedical staff time for patient care by up to 30%, reduces staff requirements, reduces hospital stay time; -flexibility: allows existing therapy to be modified and the pill to be delivered as needed: controlled directly by the patient for optimal pain management - traceability across the 6 areas involved: loader, device, patient, therapeutic changes, drugs loaded and unloaded - full integration with hospital workflow - meets all regulatory compliance requirements and guidelines for hospital drug administration The dispenser addresses a global target market of $6.3 in 2032, expected to grow by an average of 8.4 % per year until then

Target

The company has already passed the Proof Of Concept phase with its own finance and is about to embark on the experimental phase in a primary hospital facility in northern Italy. To date &euros 790k in grants and &euros 740k in equity have been raised In order to complete the industrialisation process it is necessary to: - sustain an AUCAP of maximum 300k by the end of 2024 on a pre-money value of 5 mln (share of = 5.7%) – or, by September 2025, sustain an AUCAP of maximum 1.5 mln on a pre-money value of 8.0 for the accelerated global launch.